Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μg

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00648700
Recruitment Status : Completed
First Posted : April 1, 2008
Last Update Posted : April 1, 2008
Information provided by:
Mylan Pharmaceuticals

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2005
  Study Completion Date : September 2005